Patent: 7,723,074
Summary for Patent: 7,723,074
| Title: | Nucleic acid molecules encoding prostaglandin receptor proteins |
| Abstract: | Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both. |
| Inventor(s): | Ashfaq Parkar, Paul August, Theresa Kuntzweiler, Mohamad Ali Ardati, Namadev Baskaran |
| Assignee: | Aventis Pharmaceuticals Inc |
| Application Number: | US12/348,990 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,723,074
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Sanofi Vaccines Canada Ltd. | TENIVAC | tetanus and diphtheria toxoids adsorbed | Injection | 103171 | November 3, 2003 | 7,723,074 | 2029-01-06 |
| Biomarin Pharmaceutical Inc. | ALDURAZYME | laronidase | Injection | 125058 | April 30, 2003 | 7,723,074 | 2029-01-06 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,723,074
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 047356 | ⤷ Start Trial |
| Australia | 2004312332 | ⤷ Start Trial |
| Brazil | PI0418335 | ⤷ Start Trial |
| Canada | 2551905 | ⤷ Start Trial |
| China | 1898263 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
